 Toan Ong
Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Record Linkage | 5 | 2024 | 60 | 2.310 |
Why?
| | Influenza Vaccines | 9 | 2025 | 532 | 1.350 |
Why?
| | Hospitalization | 28 | 2025 | 2057 | 1.340 |
Why?
| | Influenza, Human | 8 | 2025 | 600 | 1.120 |
Why?
| | Emergency Service, Hospital | 17 | 2025 | 1896 | 1.090 |
Why?
| | Electronic Health Records | 5 | 2024 | 973 | 1.020 |
Why?
| | Population Surveillance | 3 | 2025 | 426 | 0.860 |
Why?
| | Immunization, Secondary | 3 | 2022 | 87 | 0.840 |
Why?
| | Heart Defects, Congenital | 4 | 2020 | 747 | 0.730 |
Why?
| | Algorithms | 3 | 2024 | 1609 | 0.710 |
Why?
| | Referral and Consultation | 1 | 2024 | 724 | 0.610 |
Why?
| | Child Abuse | 1 | 2024 | 517 | 0.610 |
Why?
| | Ambulatory Care | 7 | 2024 | 500 | 0.590 |
Why?
| | Mass Screening | 1 | 2024 | 1145 | 0.530 |
Why?
| | Data Mining | 1 | 2017 | 109 | 0.520 |
Why?
| | Medical Informatics | 1 | 2014 | 99 | 0.410 |
Why?
| | Adult | 33 | 2025 | 35176 | 0.400 |
Why?
| | Biomedical Research | 2 | 2017 | 632 | 0.380 |
Why?
| | United States | 22 | 2025 | 13785 | 0.380 |
Why?
| | Adolescent | 25 | 2025 | 20158 | 0.360 |
Why?
| | Outpatients | 3 | 2022 | 366 | 0.360 |
Why?
| | Humans | 52 | 2025 | 128019 | 0.360 |
Why?
| | Vaccination | 10 | 2024 | 1343 | 0.290 |
Why?
| | Critical Illness | 2 | 2023 | 755 | 0.280 |
Why?
| | Vaccines, Combined | 5 | 2023 | 48 | 0.260 |
Why?
| | Research Design | 3 | 2025 | 1034 | 0.260 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2020 | 2428 | 0.250 |
Why?
| | RNA, Messenger | 8 | 2024 | 2669 | 0.240 |
Why?
| | Influenza A Virus, H1N1 Subtype | 2 | 2024 | 146 | 0.240 |
Why?
| | Colorado | 4 | 2024 | 4369 | 0.240 |
Why?
| | Indiana | 1 | 2024 | 33 | 0.230 |
Why?
| | Vaccines, Synthetic | 5 | 2022 | 126 | 0.230 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2024 | 34 | 0.230 |
Why?
| | Data Accuracy | 1 | 2024 | 57 | 0.220 |
Why?
| | Physical Abuse | 1 | 2024 | 39 | 0.220 |
Why?
| | Aged, 80 and over | 7 | 2025 | 7029 | 0.220 |
Why?
| | Child Protective Services | 1 | 2024 | 52 | 0.220 |
Why?
| | Aged | 13 | 2025 | 21892 | 0.220 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2020 | 3625 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2024 | 119 | 0.210 |
Why?
| | Middle Aged | 15 | 2025 | 30812 | 0.200 |
Why?
| | Male | 20 | 2025 | 62757 | 0.200 |
Why?
| | Young Adult | 13 | 2025 | 12281 | 0.200 |
Why?
| | Viral Vaccines | 1 | 2023 | 94 | 0.190 |
Why?
| | Female | 20 | 2025 | 68016 | 0.190 |
Why?
| | Child | 12 | 2025 | 20636 | 0.190 |
Why?
| | Child, Preschool | 7 | 2025 | 10378 | 0.190 |
Why?
| | Seasons | 4 | 2025 | 498 | 0.190 |
Why?
| | Information Dissemination | 1 | 2023 | 203 | 0.180 |
Why?
| | Case-Control Studies | 6 | 2023 | 3324 | 0.180 |
Why?
| | Immunocompromised Host | 1 | 2021 | 195 | 0.170 |
Why?
| | India | 4 | 2020 | 170 | 0.160 |
Why?
| | Influenza A Virus, H3N2 Subtype | 3 | 2024 | 43 | 0.160 |
Why?
| | Information Storage and Retrieval | 1 | 2020 | 108 | 0.160 |
Why?
| | Probability | 1 | 2020 | 304 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 363 | 0.150 |
Why?
| | Infant | 4 | 2025 | 8912 | 0.140 |
Why?
| | Infant, Newborn | 3 | 2024 | 5688 | 0.140 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 197 | 0.140 |
Why?
| | Comparative Effectiveness Research | 1 | 2017 | 146 | 0.130 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 263 | 0.130 |
Why?
| | Databases, Factual | 2 | 2019 | 1264 | 0.120 |
Why?
| | Mental Disorders | 1 | 2024 | 1005 | 0.120 |
Why?
| | Hospital Mortality | 3 | 2023 | 844 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 541 | 0.110 |
Why?
| | Registries | 4 | 2020 | 1873 | 0.100 |
Why?
| | Retrospective Studies | 3 | 2024 | 14404 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1354 | 0.090 |
Why?
| | Laboratories | 2 | 2021 | 109 | 0.090 |
Why?
| | Hospitals | 2 | 2024 | 631 | 0.080 |
Why?
| | Immunity, Herd | 1 | 2024 | 5 | 0.060 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2024 | 68 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 264 | 0.050 |
Why?
| | RNA, Messenger, Stored | 1 | 2022 | 8 | 0.050 |
Why?
| | Advisory Committees | 1 | 2024 | 214 | 0.050 |
Why?
| | Stakeholder Participation | 1 | 2023 | 77 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2023 | 79 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 125 | 0.050 |
Why?
| | Treatment Failure | 1 | 2022 | 338 | 0.050 |
Why?
| | Computer Simulation | 1 | 2025 | 936 | 0.040 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 22 | 0.040 |
Why?
| | Immunization Schedule | 1 | 2021 | 196 | 0.040 |
Why?
| | Logistic Models | 1 | 2025 | 1975 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 301 | 0.040 |
Why?
| | Ambulatory Care Facilities | 1 | 2021 | 226 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 409 | 0.040 |
Why?
| | Demography | 1 | 2020 | 278 | 0.040 |
Why?
| | Bias | 1 | 2020 | 196 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 490 | 0.040 |
Why?
| | Linear Models | 1 | 2019 | 816 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 710 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 734 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1211 | 0.030 |
Why?
| | Patient Readmission | 1 | 2021 | 663 | 0.030 |
Why?
| | Models, Statistical | 1 | 2019 | 621 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2614 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2541 | 0.030 |
Why?
| | Cohort Studies | 1 | 2023 | 5378 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3766 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4853 | 0.020 |
Why?
| | Time Factors | 1 | 2022 | 6479 | 0.020 |
Why?
| | Risk Factors | 1 | 2024 | 9696 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6355 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2859 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 10110 | 0.020 |
Why?
|
|
Ong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|